INS and type 2 diabetes mellitus: GHB’s capacity to protect the insulin-producing ß-cells of the pancreas from the toxic effects of high plasma levels of fatty acids may open the door to further investigation of this or related compounds as adjuvants in the treatment of type 2 diabetes.